£782k
1 period on recordActive15944501Private limited companyCambridge
SERENATIS BIO LIMITED
Significant control: Nicolas Thierry Sireau (25–50%), David John Cavalla (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Serenatis Bio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Serenatis Bio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SERENATIS BIO LIMITED is an active private limited company (company number 15944501) incorporated on 9 September 2024, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 September 2025, showing net assets of £782k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
Peer position · net assets
By net assets it sits in the top quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Dr Nicolas Thierry Sireau
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr David John Cavalla
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 9 September 20242 yrs ago
- Next accounts due
- 30 June 2027in 244 days
- Confirmation statement due
- 23 September 2027in 329 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
1 period on record| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £782k | — | — | £34k | — | — | 2 |
Current ratio20.94Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £781,751 at 30 September 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 20.94
- Incorporated two to five years agoIncorporated 9 September 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 329 days
- Next accounts duein 244 days
- Accounts period endNet assets £782k · micro accounts
- Incorporated
08
Similar companies in Cambridge
- BINDBRIDGE LTDImpington · inc. Sept 2024
- SERRAO HALIM LIMITEDCambridge · inc. Aug 2024
- EFFERVESCENCE THERAPEUTICS LTDCambridge · inc. Sept 2024
- BIOPHILIA LIMITEDSaffron Walden · inc. Oct 2024
- PRODROMIC LTDWaterbeach · inc. Jul 2024
- ELECTRA BIO LTDCambridge · inc. Oct 2024
All companies incorporated on 9 September 2024 · in Sept 2024.
09
Reminders for SERENATIS BIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.